11 – 20 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
- Contribution to journal › Debate/Note/Editorial
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer : Working Group 3: Subcategorization of T1 Bladder Cancer
- Contribution to journal › Article
-
Mark
Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria
- Contribution to journal › Article
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
-
Mark
The Importance of Being Grade 3 : A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non–muscle-invasive Bladder Cancer
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
- Contribution to journal › Scientific review
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
- Contribution to journal › Article
-
Mark
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization
- Contribution to journal › Article
